In a significant recognition that underscores our commitment to innovation and excellence, Armis has been honored with the prestigious 2024 Frost & Sullivan Technology Innovation Leadership Award for Global Healthcare Cybersecurity Industry Excellence in Best Practices. This recognition holds special significance to us, being named as an innovation leader in cybersecurity for healthcare, one of the most vulnerable and essential industries. This award validates our dedication to continually innovating in order to ensure essential patient care remains protected from the evolving threat landscape.
According to David Frigstad, Frost & Sullivan Chairman, “Frost & Sullivan reserves this recognition for companies at the forefront of innovation and growth in their respective industries. These companies consolidate their leadership positions by innovating and creating new products, solutions, and services that meet ever-evolving customer needs.” Frost & Sullivan applied a rigorous analytical process to evaluate multiple healthcare cybersecurity vendors before selecting Armis for this award. Vendors were evaluated according to the following award criteria:
The detailed Frost & Sullivan Technology Innovation Leadership Award report highlights Armis’ unmatched cybersecurity solution, calling us “The most advanced cyber exposure management platform.” This award adds to a series of many recognitions for Armis in recent months that further underscore our leadership and commitment to the field and serve to establish a legacy of recognition and pursuit of growth. I am particularly honored to be recognized for our contributions to healthcare cybersecurity.
The report notes that “In the healthcare sector, stakeholders must select top-tier technology-based solutions to maximize their market impact. Frost & Sullivan recognizes Armis Centrix™ for providing unmatched cybersecurity protection within this framework. This advanced platform ensures global visibility, security, and management of an extensive range of assets, effectively mitigating risks, remediating vulnerabilities, and thwarting threats.” This glowing statement captures the essence of our mission – to provide the healthcare industry with the most comprehensive and robust cybersecurity solutions available.
Unified Focus on Proactive Protection
At Armis, every department and individual is unified in our focus on making a positive difference for our customers. We understand the critical importance of cybersecurity in healthcare and are committed to providing solutions that see, protect, and manage the entire attack surface. This award acknowledges our platform across the following key areas:
- Armis is the Most Advanced Cyber Exposure Management Platform: Armis Centrix™ provides global visibility and security, mitigates cyber asset risks, remediates vulnerabilities, and blocks threats, prioritizing action based on business-critical factors.
- Fostering Innovation, Security, and Compliance: Armis regularly interacts with partners to gather insights and monitor progress, and continues to innovate and expand our product suites. We also support essential compliance and security frameworks, provide in-depth device insights, and utilize these insights to inform the development of new initiatives.
- Exceptional Customer Success Strategy: Our dedication to and collaboration with our customers and agile development result in swift time to value and rapid deployment of new features. We have seen impressive adoption rates of our most recent product offerings, bolstering our protection and relationship with customers such as Main Line Health, Burke Rehabilitation & Research Center, and Mater University Hospital, Dublin.
Comprehensive Protection Across All Assets
Armis provides a unique offering that not only protects medical devices, but rather covers the entire attack surface, from IoMT assets to IoT, IT, and OT assets. This allows Armis to provide more comprehensive coverage for even the most sensitive assets with its multi-discipline detection engine. Armis Centrix™ is uniquely positioned to deliver value across our five award-winning product suites.
According to Manuel Albornoz, Best Practices Research Analyst at Frost & Sullivan, “The platform’s overarching distinction is that, through a single pane of glass, it provides a real-time, contextual view of the environment and security posture, monitoring and managing all assets affecting patient care, including IT, OT, IoT, medical devices, enterprise assets, and cloud infrastructure. In addition to this robust visibility, Armis offers cutting-edge threat intelligence and forensic monitoring capabilities.”
We are keenly aware of the criticality of cybersecurity in healthcare and the importance of being able to proactively protect the entire attack surface and avoid patient disruption. We are so pleased that this Frost & Sullivan Technology Innovation Award recognizes our entire Armis Centrix™ platform as a leading cybersecurity product in healthcare and highlights our products Armis Centrix™ for Medical Device Security, Armis Centrix™ for Actionable Threat Intelligence, and Armis Centrix™ for VIPR – Prioritization and Remediation and key platform features such as our investment in artificial intelligence (AI) and our Asset Intelligence Engine.
The report concludes, “The company’s relentless pursuit of innovation, strategic acquisitions, and expansion into new markets ensures its continued growth and leadership in the cybersecurity landscape.”
I invite you to download a copy of the report for a more in-depth view of why Armis received the 2024 Frost & Sullivan Technology Innovation Leadership Award. And I look forward to our continued growth and innovation in the healthcare industry and across all industries.